On this edition of Managed Care Cast, we present a short excerpt from a January webinar titled “Color and COVID-19: The Virus’ Disproportionate Impact” hosted by the MJH Life Sciences™ COVID-19 Coalition about how the pandemic has had an unequal, devastating impact on communities of color.
January 2021 was the deadliest month of the coronavirus disease 2019 (COVID-19) pandemic in the United States, with daily average deaths of 3076 a day, according to the Petersen-KFF Health System Tracker. And on Monday, the country passed the devastating marker of 500,000 deaths since the first US death was recorded a year ago.
However, Americans have not been affected by this virus equally.
Last month, during a webinar titled “Color and COVID-19: The Virus’ Disproportionate Impact” hosted by the MJH Life Sciences™ COVID-19 Coalition, experts discussed how the virus has affected communities of color, vaccine distribution and uptake, and their visions for the future.
On this edition of Managed Care Cast, we present a short excerpt from the webinar.
“These numbers representing the really painful disproportionate toll that the virus is taking is just a subset of the discussion,” Utibe Essien, MD, MPH, assistant professor of medicine at the University of Pittsburgh School of Medicine, who moderated the event, said in a white paper about 10 takeaways from the webinar.
Essien was joined by:
Watch the entire webinar here and register for the next webinar, “Legal and Ethical Considerations of COVID-19 Vaccination” on Wednesday, February 24, 2021, at 6 pm ET, here.
Listen above or through one of these podcast services:
Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells
August 1st 2025Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
Read More
Updated mRNA Vaccines Against JN.1 Show Strong Safety Signal in Real-World Data
July 31st 2025A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and supporting continued use in high-risk populations amid ongoing viral evolution.
Read More
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More